This Big-Cap "Ebola Stock" Is Also a Dividend Aristocrat

Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the most likely Ebola vaccine. I'm not taking you on any wild rides like that. Instead, check out this solid big-cap company that's gearing up for a major Ebola drug trial. The post This Big-Cap "Ebola Stock" Is Also a Dividend Aristocrat appeared first on Money Morning - Only the News You Can Profit From .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.